TGF-B secretion by stromal cells enhances metastatic capacity in colorectal cancer [75], while in PDAC, it induces a myofibroblastic phenotype of cancer-associated fibroblasts via EGFR/ERBB2 signalling, promoting metastasis [76]. Here, ERBB2 is linked to colorectal cancer.